Dr Reddys posted its results for the fourth quarter and full year of FY26 on Tuesday, missing estimates as the loss of exclusivity for blood cancer drug Lenalidomide in the US market, as well as impairments from its CAR-T assets and discontinued licensed product Eftilagimod Alfa, weighed it down
For this reason, patients who have had, or have family members who have ever had medullary thyroid carcinoma should not use liraglutide, nor should patients who have an endocrine system condition called multiple endocrine neoplasia syndrome type 2
For daytime, follow with a broad-spectrum sunscreen to protect your revitalized skin
"Since long-term use of steroids has a lot of side effects, dermatologists are always looking for steroid-sparing agents." Dr
Our team educates and empowers every individual to recognize success in more meaningful ways